Awarded
Lote 3. Inrebic (Fedratinib)
Track this recordFree account — get alerted when a contract here runs out.
- Winners
- BRISTOL-MYERS SQUIBB, S.A.U.
- Contract value
- €83,369
- Bids received
- 1
- Published
- 23 Sept 2026
- Awarded
- 21 Sept 2026
- Contract start
- 21 Sept 2026
- Contract end
- 22 Sept 2027estimated
- Region
- Cantabria
More awards from this buyer
| Awarded | Buyer | Winner | Contract value | Published |
|---|---|---|---|---|
| Lote 8. Vectibix (Panitumumab) | Servicio Cántabro de Salud | AMGEN S.A. | €2,481,004 | 23 Sept 2026 |
| Lote 7. Uplizna (Inebilizumab) | Servicio Cántabro de Salud | AMGEN S.A. | €3,063,600 | 23 Sept 2026 |
| Lote 5. Parsabiv (Etelcalcetida Hidrocloruro) | Servicio Cántabro de Salud | AMGEN S.A. | €1,222,560 | 23 Sept 2026 |
| Lote 4. Nplate (Romiplostim) | Servicio Cántabro de Salud | AMGEN S.A. | €776,001 | 23 Sept 2026 |
| Lote 3. Lumykras (Sotorasib) | Servicio Cántabro de Salud | AMGEN S.A. | €852,480 | 23 Sept 2026 |
| Lote 1. Blincyto (Blinatumomab) | Servicio Cántabro de Salud | AMGEN S.A. | €2,307,700 | 23 Sept 2026 |